Outcomes of venovenous-extracorporeal membrane oxygenation bridging in lung transplant recipients with panel reactive antibody positivity
Journal of Artificial Organs · 2026
DOI: 10.1007/s10047-025-01539-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Artificial Organs, 2026. Verfasst von Austin Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL,…. Hauptthemen laut MEDLINE: Lung Transplantation, Extracorporeal Membrane Oxygenation, Postoperative Complications. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung transplantation improves survival in advanced lung disease, but calculated Panel Reactive Antibody (cPRA) positive patients are at higher risk for adverse outcomes. It is unclear if sensitization poses additional risks in patients bridged to transplantation with venovenous extracorporeal membrane oxygenation (VV-ECMO). This study compares outcomes between cPRA-positive and -negative patients bridged with VV-ECMO.
Methods
Among 411 transplant recipients from an institutional lung transplantation database (January 2018–March 2025), 52 patients were bridged with VV-ECMO. Of these, 14 were cPRA-positive and 38 were cPRA-negative. Univariate and multivariate analyses evaluated early post-transplant complications and survival outcomes in cPRA-positive and -negative groups.
Results
Rates of post-transplant complications such as primary graft dysfunction (PGD) in any grade (85.7% cPRA-positive vs. 76.4% cPRA-negative, p = 0.48), PGD grade 3 (35.7% vs. 50.0%, p = 0.53), acute kidney injury (AKI) (64.3% vs. 68.4%, p = 1.00), dialysis requirement (21.4% vs. 34.2%, p = 0.51), deep vein thrombosis (DVT) (71.4% vs. 55.3%, p = 0.35), and pulmonary embolism (PE) (7.1% vs. 18.4%, p = 0.42) were similar. 1-year survival rate (85.1% vs. 82.9%) and overall survival ( p = 0.81) were not significantly different.
Conclusions
Post-transplant outcomes and survival were similar between cPRA-positive and -negative groups, suggesting that PRA status in VV-ECMO bridged lung transplant recipients is not associated with worse outcomes. VV-ECMO may remain a viable bridge to lung transplantation, even in sensitized patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA.
- Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA. miyasea1225@gmail.com.
- Division of Pulmonary and Critical Care, Department of Medicine, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA.
- Division of Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, 676 N. St Clair St, Suite 650, Chicago, IL, 60611, USA. chitaru.kurihara@northwestern.edu.
Zitieren
APA
Chang, A., Miyashita, Y., Thomae, B. L., Kamar, A., Kaiho, T., & Kurihara, C. (2026). Outcomes of venovenous-extracorporeal membrane oxygenation bridging in lung transplant recipients with panel reactive antibody positivity. Journal of Artificial Organs. https://doi.org/10.1007/s10047-025-01539-2
Vancouver
Chang A, Miyashita Y, Thomae BL, Kamar A, Kaiho T, Kurihara C. Outcomes of venovenous-extracorporeal membrane oxygenation bridging in lung transplant recipients with panel reactive antibody positivity. Journal of Artificial Organs. 2026. doi:10.1007/s10047-025-01539-2
BibTeX
@article{Chang2026,
author = {Chang, Austin and Miyashita, Yudai and Thomae, Benjamin Louis and Kamar, Amanda and Kaiho, Taisuke and Kurihara, Chitaru},
title = {Outcomes of venovenous-extracorporeal membrane oxygenation bridging in lung transplant recipients with panel reactive antibody positivity},
journal = {Journal of Artificial Organs},
year = {2026},
doi = {10.1007/s10047-025-01539-2}
}
EUVIMED